Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Astrana Health ( (ASTH) ).
On March 4, 2026, Astrana Health, Inc. updated its corporate investor presentation for use at conferences and meetings, highlighting its delegated financial model and role as a risk-bearing organization in value-based care. The materials describe how Astrana’s ecosystem keeps members within its network across payers, offers payer-like administrative services, and supports providers with care coordination to improve patient outcomes and cost control as it scales into new markets nationwide.
The presentation underscores Astrana’s focus on transforming the traditional fee-for-service healthcare status quo into accessible, high-quality, and coordinated care delivery. By emphasizing its platform for delegated risk, expanded national footprint, and use of non-GAAP performance metrics such as Adjusted EBITDA and free cash flow, the company signals its operational strategy and positioning to investors, payers, and providers in the competitive value-based care landscape.
The most recent analyst rating on (ASTH) stock is a Hold with a $28.00 price target. To see the full list of analyst forecasts on Astrana Health stock, see the ASTH Stock Forecast page.
Spark’s Take on ASTH Stock
According to Spark, TipRanks’ AI Analyst, ASTH is a Neutral.
The score is driven by solid cash generation and constructive guidance, partially offset by margin compression and higher leverage in recent results. Technicals are supportive with the stock above key moving averages, but valuation is a notable headwind due to the very high P/E.
To see Spark’s full report on ASTH stock, click here.
More about Astrana Health
Astrana Health, Inc. operates in the U.S. healthcare services sector, focusing on delegated risk and value-based care through coordinated delivery networks. The company partners with primary care, multi-specialty providers, and hospitals across multiple payers and lines of business to manage medical costs, enhance care quality, and reduce administrative burdens for providers.
Average Trading Volume: 566,784
Technical Sentiment Signal: Sell
Current Market Cap: $1.32B
See more insights into ASTH stock on TipRanks’ Stock Analysis page.